Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marty Chaplin

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Pharmacoeconomics - Open|December 5, 2023
Correction: Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15Marty Chaplin, Rebecca Bresnahan, Nigel Fleeman, et al.
The Cochrane Database of Systematic Reviews|November 19, 2024
Vaccines for preventing Ebola virus diseaseRebecca Kuehn, Hannah Ryan, Kevin C Okwaraeke, et al.
The Cochrane Database of Systematic Reviews|July 24, 2022
Accuracy of measures for antiretroviral adherence in people living with HIVRhodine Smith, Gemma Villanueva, Katrin Probyn, et al.
Pharmacoeconomics - Open|April 21, 2023
Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology AppraisalRachel Houten, Nigel Fleeman, James Mahon, et al.
The Cochrane Database of Systematic Reviews|March 11, 2026
High-intensity interval training for reducing cardiometabolic syndrome in healthy but sedentary populationsJuliette A Strauss, Richard Kirwan, Chathuranga Ranasinghe, et al.
Health Technology Assessment (Winchester, England)|October 15, 2023
Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluationRebecca Bresnahan, Rui Duarte, James Mahon, et al.
Pharmacoeconomics - Open|May 17, 2023
Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology AppraisalRebecca Bresnahan, Rachel Houten, Janette Greenhalgh, et al.
Health Technology Assessment (Winchester, England)|September 10, 2024
Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysisNigel Fleeman, Rachel Houten, Sarah Nevitt, et al.
Health Technology Assessment (Winchester, England)|March 30, 2026
Interventions to safely and effectively reduce (taper) use of opioids in chronic non-cancer pain: a systematic reviewRuaraidh Hill, Michelle Maden, Rui Duarte, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Pharmacoeconomics - Open|December 5, 2023
Correction: Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15Marty Chaplin, Rebecca Bresnahan, Nigel Fleeman, et al.
The Cochrane Database of Systematic Reviews|November 19, 2024
Vaccines for preventing Ebola virus diseaseRebecca Kuehn, Hannah Ryan, Kevin C Okwaraeke, et al.
The Cochrane Database of Systematic Reviews|July 24, 2022
Accuracy of measures for antiretroviral adherence in people living with HIVRhodine Smith, Gemma Villanueva, Katrin Probyn, et al.
Pharmacoeconomics - Open|April 21, 2023
Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology AppraisalRachel Houten, Nigel Fleeman, James Mahon, et al.
The Cochrane Database of Systematic Reviews|March 11, 2026
High-intensity interval training for reducing cardiometabolic syndrome in healthy but sedentary populationsJuliette A Strauss, Richard Kirwan, Chathuranga Ranasinghe, et al.
Health Technology Assessment (Winchester, England)|October 15, 2023
Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluationRebecca Bresnahan, Rui Duarte, James Mahon, et al.
Pharmacoeconomics - Open|May 17, 2023
Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology AppraisalRebecca Bresnahan, Rachel Houten, Janette Greenhalgh, et al.
Health Technology Assessment (Winchester, England)|September 10, 2024
Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysisNigel Fleeman, Rachel Houten, Sarah Nevitt, et al.
Health Technology Assessment (Winchester, England)|March 30, 2026
Interventions to safely and effectively reduce (taper) use of opioids in chronic non-cancer pain: a systematic reviewRuaraidh Hill, Michelle Maden, Rui Duarte, et al.
Pageof 3